NCT07619521 2026-06-02Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal AdenocarcinomaNational Cancer Institute (NCI)Phase 1/2 Not yet recruiting31 enrolled